tickrz reports
  
tickrz rank
A
CVS Health Corp (CVS)
Healthcare | Health Care Plans
CEO: Larry J. Merlo
Employees: 243000
cvshealth.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank43Dividend Rank176
Moat Rank63Financial Strength Rank120
Growth Rank126Momentum Rank479
DIVIDEND ANALYSIS
Dividend Yield2.42%
Payout Ratio36.8%
3 yr Dividend Growth23.17%
VALUATION RATIOS
P/E Ratio15.42x
P/B Ratio2.33x
P/S Ratio0.44x
EV/EBITDA Ratio8.38x
FINANCIAL STRENGTH
Piotroski F-Score6
Debt-to-Equity81%
Interest Coverage5.96x
MOAT
ROE14.67%
ROIC10.23%
Net Margin2.98%
GROWTH
5 yr EPS Growth13.46%
5 yr SPS Growth10.64%
5 yr BPS Growth3.44%
tickrz A-Ranked CVS Health Corp scores well on valuation
 tickrz summary
CVS Health Corp receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CVS Health Corp's valuation score is comprised of a P/E ratio of 15.4x, a P/B ratio of 2.3x, a P/S ratio of 0.4x, and an EV/EBITDA ratio of 8.4x. CVS Health Corp ranks 43 out of the S&P 500 constituents on valuation--a relatively strong score.CVS Health Corp ranks 5 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CVS Health Corp warrants further investigation.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is strong. CVS Health Corp appears to have a durable competitive advantage within the Healthcare sector. CVS Health Corp has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 5.96x, a debt/equity ratio of 81% and a Moat Rank of 63 translate to a strong Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -22.9% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 479. Based on its 12 month stock performance, CVS Health Corp will not appeal to momentum investors.

 yield
 value + yield
Shares currently yield 2.42%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CVS Health Corp ranks 176 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 13.5% 5 year annualized EPS growth, 10.6% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% speak to its impressive growth ranking.

CVS Health Corp (CVS)
Healthcare | Health Care Plans
CEO: Larry J. Merlo
Employees: 243000
cvshealth.com


tickrz rank
A

VALUATION RATIOS
P/E Ratio15.42x
P/B Ratio2.33x
P/S Ratio0.44x
EV/EBITDA Ratio8.38x
DIVIDEND ANALYSIS
Dividend Yield2.42%
Payout Ratio36.8%
3 yr Dividend Growth23.17%
FINANCIAL STRENGTH
Piotroski F-Score6
Debt-to-Equity81%
Interest Coverage5.96x
MOAT
ROE14.67%
ROIC10.23%
Net Margin2.98%
GROWTH
5 yr EPS Growth13.46%
5 yr SPS Growth10.64%
5 yr BPS Growth3.44%

TICKRZ RANK
CVS Health Corp receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CVS Health Corp's valuation score is comprised of a P/E ratio of 15.4x, a P/B ratio of 2.3x, a P/S ratio of 0.4x, and an EV/EBITDA ratio of 8.4x. CVS Health Corp ranks 43 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
CVS Health Corp ranks 5 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CVS Health Corp warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is strong. CVS Health Corp appears to have a durable competitive advantage within the Healthcare sector.

FINANCIAL STRENGTH
CVS Health Corp has a Piotroski F Score of 6 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 5.96x, a debt/equity ratio of 81% and a Moat Rank of 63 translate to a strong Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -22.9% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 479. Based on its 12 month stock performance, CVS Health Corp will not appeal to momentum investors.

VALUE + YIELD
Shares currently yield 2.42%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CVS Health Corp ranks 176 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 13.5% 5 year annualized EPS growth, 10.6% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% speak to its impressive growth ranking.